Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Receivables: 2024

Historic Change in Receivables for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $13.9 million.

  • Day One Biopharmaceuticals' Change in Receivables fell 573.92% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year change of. This contributed to the annual value of $13.9 million for FY2024, which is N/A change from last year.
  • Day One Biopharmaceuticals' Change in Receivables amounted to $13.9 million in FY2024.
  • In the past 5 years, Day One Biopharmaceuticals' Change in Receivables ranged from a high of $13.9 million in FY2024 and a low of $13.9 million during FY2024.
  • Moreover, its 1-year median value for Change in Receivables was $13.9 million (2024), whereas its average is $13.9 million.